Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Indivior Pharmaceuticals, Inc. - Common Stock
(NQ:
INDV
)
33.17
+0.01 (+0.03%)
Streaming Delayed Price
Updated: 2:41 PM EDT, Apr 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Indivior Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder
Today 11:00 EDT
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Shows High Growth Momentum and Technical Breakout Potential
↗
April 21, 2026
Via
Chartmill
Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse
April 16, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th
April 09, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Pharmaceuticals Inc (NASDAQ:INDV) Surpasses Q4 2025 Estimates and Provides Strong 2026 Outlook
↗
February 26, 2026
Via
Chartmill
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Setup Case
↗
February 20, 2026
Via
Chartmill
INDIVIOR PHARMACEUTICALS INC (NASDAQ:INDV) Presents a High-Growth Momentum Breakout Setup
↗
January 27, 2026
Via
Chartmill
New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities
March 31, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder
March 17, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering
March 12, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Announces Proposed Convertible Senior Notes Offering
March 12, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder
March 11, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Divisadero Dumps Stride Stock
↗
March 06, 2026
Stride delivers technology-driven education solutions for K–12 and adult learners, serving schools, districts, and employers nationwide.
Via
The Motley Fool
Topics
Regulatory Compliance
Indivior (INDV) Q4 2025 Earnings Call Transcript
↗
February 26, 2026
Indivior (INDV) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Indivior Reports Fourth Quarter and Full-Year 2025 Financial Results
February 26, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior to Participate in Upcoming Investor Conferences
February 24, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet
↗
February 22, 2026
Vistance Networks delivers connectivity and network solutions for telecom, data centers, and enterprise clients worldwide.
Via
The Motley Fool
Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth
↗
February 22, 2026
Array Digital Infrastructure delivers wireless services and device sales to consumers, businesses, and government clients nationwide.
Via
The Motley Fool
Topics
Regulatory Compliance
Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio
↗
February 22, 2026
Enviri delivers environmental and specialty waste solutions for industrial clients through long-term contracts and value-added products.
Via
The Motley Fool
Topics
Regulatory Compliance
Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround
↗
February 22, 2026
Integer Holdings supplies medical device components and finished products to major OEMs in cardiac, neuro, and surgical markets.
Via
The Motley Fool
Topics
Regulatory Compliance
Indivior to Report Fourth Quarter and Full-Year 2025 Financial Results and Host Webcast on February 26ᵗʰ
January 28, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Announces Completion of Redomiciliation to the United States
January 26, 2026
From
Indivior Pharmaceuticals Inc.
Via
GlobeNewswire
Indivior Provides Full-Year 2026 Financial Guidance and Business Update
January 08, 2026
From
Indivior Inc.
Via
GlobeNewswire
Mangrove Partners Loads Up Flywire With 2.9 Million Shares
↗
December 30, 2025
The new holding places Flywire outside the fund’s top five positions.
Via
The Motley Fool
Topics
Regulatory Compliance
INDIVIOR PLC (NASDAQ:INDV) Presents a High-Growth Momentum and Technical Breakout Setup
↗
December 29, 2025
INDIVIOR stock combines high-growth earnings momentum with a strong technical uptrend and a current bull flag setup for a potential breakout.
Via
Chartmill
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table
↗
December 28, 2025
When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.
Via
The Motley Fool
Topics
Regulatory Compliance
Bardin Hill Dumps 349,000 Shares of Frontier Communicaitons Stock Worth $12.7 Million
↗
December 18, 2025
The position previously accounted for 7.48% of fund AUM as of the prior quarter.
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake?
↗
December 07, 2025
A newly public real-estate platform is putting up numbers that look far more seasoned than its age.
Via
The Motley Fool
Topics
Regulatory Compliance
Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock
↗
December 07, 2025
One fund just made a bold bet on a telecom stock undergoing a big transformation
Via
The Motley Fool
Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge
↗
December 07, 2025
This fund just doubled down on a stock that’s suddenly delivering the earnings momentum it’s promised for years.
Via
The Motley Fool
Topics
Regulatory Compliance
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit